Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00545064 |
To evaluate if preservative free cosopt is well tolerated in patients with Open angle glaucoma (OAG) or Ocular hypertension (OH) with dry eyes.
Condition | Intervention | Phase |
---|---|---|
Ocular Hypertension Open Angle Glaucoma |
Drug: dorzolamide hydrochloride (+) timolol maleate |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | A Multicenter, Open-Label Study To Evaluate The Tolerability Of Preservative Free Dorzolamide-Timolol Therapy In Patients Untreated With Open-Angle Glaucoma Or Ocular Hypertension And Dry Eye(S) |
Enrollment: | 170 |
Study Start Date: | May 2007 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Merck & Co., Inc. ( Executive Vice President, Clinical and Quantitative Sciences ) |
Study ID Numbers: | 2007_026, MK0507A-152 |
Study First Received: | October 16, 2007 |
Last Updated: | September 8, 2008 |
ClinicalTrials.gov Identifier: | NCT00545064 History of Changes |
Health Authority: | Canada: Canadian Institutes of Health Research |
Neurotransmitter Agents Adrenergic Agents Eye Diseases Vascular Diseases Cardiovascular Agents Antihypertensive Agents Carbonic Anhydrase Inhibitors Glaucoma |
Glaucoma, Open-Angle Adrenergic beta-Antagonists Adrenergic Antagonists Timolol Anti-Arrhythmia Agents Ocular Hypertension Hypertension Dorzolamide |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Eye Diseases Physiological Effects of Drugs Vascular Diseases Enzyme Inhibitors Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions Carbonic Anhydrase Inhibitors |
Glaucoma Therapeutic Uses Glaucoma, Open-Angle Adrenergic beta-Antagonists Cardiovascular Diseases Adrenergic Antagonists Anti-Arrhythmia Agents Timolol Hypertension Ocular Hypertension Dorzolamide |